7.06
price down icon3.42%   -0.25
 
loading
Schlusskurs vom Vortag:
$7.31
Offen:
$7.1
24-Stunden-Volumen:
572.20K
Relative Volume:
1.05
Marktkapitalisierung:
$1.04B
Einnahmen:
$342.81M
Nettoeinkommen (Verlust:
$97.67M
KGV:
11.49
EPS:
0.6145
Netto-Cashflow:
$50.46M
1W Leistung:
-6.37%
1M Leistung:
-12.84%
6M Leistung:
+22.57%
1J Leistung:
+0.57%
1-Tages-Spanne:
Value
$6.93
$7.28
1-Wochen-Bereich:
Value
$6.93
$7.75
52-Wochen-Spanne:
Value
$5.47
$10.14

Mimedx Group Inc Stock (MDXG) Company Profile

Name
Firmenname
Mimedx Group Inc
Name
Telefon
(770) 651-9100
Name
Adresse
1775 W OAK COMMONS COURT, NE, MARIETTA
Name
Mitarbeiter
837
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
MDXG's Discussions on Twitter

Vergleichen Sie MDXG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
6.49 0 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
19.95 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.16 337.66M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.265 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.25 139.95M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
10.50 137.23M 0 0 0 0.00

Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-02 Eingeleitet Cantor Fitzgerald Overweight
2024-03-07 Eingeleitet Lake Street Buy
2023-10-27 Eingeleitet Craig Hallum Buy
2022-10-13 Eingeleitet Mizuho Buy
2021-07-26 Eingeleitet Northland Capital Outperform
2021-03-19 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Mimedx Group Inc Aktie (MDXG) Neueste Nachrichten

pulisher
09:54 AM

Tendonitis Market Growth Projections 2024-2034: DelveInsight Analysis | TRB Chemedica, CollPlant, Novartis, Orthocell, MiMedX group, InGeneron, R3 Stem Cell - The Globe and Mail

09:54 AM
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Purchases 5,250 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

Amniotic Membrane Market Focusing on Growth and Innovations - openPR.com

Mar 31, 2025
pulisher
Mar 28, 2025

Avantax Advisory Services Inc. Reduces Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

MiMedx Group (NASDAQ:MDXG) Seems To Use Debt Rather Sparingly - simplywall.st

Mar 27, 2025
pulisher
Mar 25, 2025

Proficio Capital Partners LLC Purchases Shares of 46,089 MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

MiMedx Group, Inc.'s (NASDAQ:MDXG) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance

Mar 24, 2025
pulisher
Mar 22, 2025

Charles Schwab Investment Management Inc. Decreases Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Top Executive Sells Shares in MiMedx Group! - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

MiMedx Challenges FDA Classification Of Wound Care Powder - Law360

Mar 20, 2025
pulisher
Mar 20, 2025

Mimedx group chief commercial officer sells shares worth $14,142 By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Mimedx group chief commercial officer sells shares worth $14,142 - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

MiMedx Group Executive Sells Shares to Cover Tax Liability - TradingView

Mar 20, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Has $1.32 Million Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Bank of New York Mellon Corp Has $4.85 Million Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Head-To-Head Analysis: MiMedx Group (NASDAQ:MDXG) and Stevanato Group (NYSE:STVN) - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

Top Executives Unload Significant Shares of MiMedx Group - TipRanks

Mar 15, 2025
pulisher
Mar 15, 2025

Mimedx group’s general counsel sells $430,762 in stock By Investing.com - Investing.com South Africa

Mar 15, 2025
pulisher
Mar 15, 2025

Mimedx chief commercial officer sells shares for $32,396 By Investing.com - Investing.com Canada

Mar 15, 2025
pulisher
Mar 14, 2025

Mimedx group’s general counsel sells $430,762 in stock - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Mimedx chief commercial officer sells shares for $32,396 - Investing.com India

Mar 14, 2025
pulisher
Mar 12, 2025

Mimedx group general counsel sells $635,278 in stock By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Mimedx group general counsel sells $635,278 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Where are the Opportunities in (MDXG) - Stock Traders Daily

Mar 11, 2025
pulisher
Mar 11, 2025

Dermal Regeneration Template Market May Set a New Growth Story |Poietis , MiMedx Group - openPR

Mar 11, 2025
pulisher
Mar 11, 2025

Proficio Capital Partners LLC Acquires Shares of 46,089 MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Principal Financial Group Inc. Grows Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Mimedx group chief commercial officer sells $17,742 in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Reviewing ICU Medical (NASDAQ:ICUI) and MiMedx Group (NASDAQ:MDXG) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Mimedx group chief commercial officer sells $17,742 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Some May Be Optimistic About MiMedx Group's (NASDAQ:MDXG) Earnings - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

New York State Common Retirement Fund Buys 27,867 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

MiMedx Group, Inc. (NASDAQ:MDXG) Position Reduced by Rhumbline Advisers - Defense World

Mar 05, 2025
pulisher
Mar 03, 2025

MiMedx Earnings Call: Growth Amidst Challenges - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Cantor Fitzgerald Comments on MiMedx Group FY2025 Earnings - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Northland Capmk Forecasts Reduced Earnings for MiMedx Group - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Wolf Haldenstein: Mimedx Investor Reminder - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Brokerages Set MiMedx Group, Inc. (NASDAQ:MDXG) Target Price at $12.00 - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Northland Capmk Forecasts Higher Earnings for MiMedx Group - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MiMedx Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 25, 2018 – MDXG - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Beyond the Balance Sheet: What SWOT Reveals About MiMedx Group I - GuruFocus

Feb 28, 2025
pulisher
Feb 27, 2025

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

When and Where to Catch MIMEDX's Latest Investor Presentation at the TD Cowen Conference - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

MiMedx Group Inc (MDXG) Q4 2024 Earnings: Revenue Surpasses Esti - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

MiMedx: Q4 Earnings Snapshot - mySA

Feb 27, 2025
pulisher
Feb 27, 2025

MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Feb 27, 2025

Finanzdaten der Mimedx Group Inc-Aktie (MDXG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Mimedx Group Inc-Aktie (MDXG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Hulse William Frank IV
General Counsel and CAO
Mar 13 '25
Sale
7.89
54,596
430,762
440,178
Maersk-Moller Kimberly
Chief Commercial Officer
Mar 13 '25
Sale
7.89
4,106
32,396
310,836
Hulse William Frank IV
General Counsel and CAO
Mar 10 '25
Sale
7.80
81,446
635,279
494,774
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):